Reischig, T <br/><br/>
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation.  [electronic resource] 

 -  American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons  Jan 2008 
 - 69-77 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1600-6143 
<br/><br/><label>Standard No.: </label>10.1111/j.1600-6143.2007.02031.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acyclovir--analogs & derivatives<br/>Adult<br/>Aged<br/>Antiviral Agents--economics<br/>Cytomegalovirus<br/>Cytomegalovirus Infections--economics<br/>Czech Republic--epidemiology<br/>Ganciclovir--analogs & derivatives<br/>Humans<br/>Incidence<br/>Kidney Transplantation--adverse effects<br/>Middle Aged<br/>Prospective Studies<br/>Valacyclovir<br/>Valganciclovir<br/>Valine--analogs & derivatives